Mario Gabelli's BMRN Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 13,150 shares of BioMarin Pharmaceutical Inc. (BMRN) worth $712,204, representing 0.01% of the portfolio. First purchased in 2017-Q4, this long-term strategic position has been held for 32 quarters.
Based on 13F filings, Mario Gabelli has maintained a strategic position in BMRN, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2021, adding 6,504 shares. Largest reduction occurred in Q4 2021, reducing 5,653 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's BioMarin Pharmaceutical (BMRN) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioMarin Pharmaceutical (BMRN) Trades by Mario Gabelli
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2017 | +2,600 | New Buy | 2,600 | $89.23 |
| Q2 2018 | -300 | Reduce 11.54% | 2,300 | $94.35 |
| Q4 2018 | -2,300 | Sold Out | 2,300 | $0.00 |
| Q1 2019 | +2,300 | New Buy | 2,300 | $88.70 |
| Q2 2019 | -2,300 | Sold Out | 2,300 | $0.00 |
| Q4 2020 | +4,270 | New Buy | 4,270 | $87.59 |
| Q1 2021 | +6,504 | Add 152.32% | 10,774 | $75.55 |
| Q2 2021 | +30 | Add 0.28% | 10,804 | $83.40 |
| Q3 2021 | -386 | Reduce 3.57% | 10,418 | $77.27 |
| Q4 2021 | -5,653 | Reduce 54.26% | 4,765 | $88.35 |
| Q1 2022 | -703 | Reduce 14.75% | 4,062 | $77.06 |
| Q2 2022 | -660 | Reduce 16.25% | 3,402 | $82.89 |
| Q3 2022 | +95 | Add 2.79% | 3,497 | $84.64 |
| Q4 2022 | -243 | Reduce 6.95% | 3,254 | $103.49 |
| Q1 2023 | +290 | Add 8.91% | 3,544 | $97.24 |
| Q2 2023 | -360 | Reduce 10.16% | 3,184 | $86.68 |
| Q3 2023 | -470 | Reduce 14.76% | 2,714 | $88.48 |
| Q4 2023 | -231 | Reduce 8.51% | 2,483 | $96.42 |
| Q1 2024 | -2,483 | Sold Out | 2,483 | $0.00 |
| Q2 2024 | +5,315 | New Buy | 5,315 | $82.33 |
| Q3 2024 | +1,250 | Add 23.52% | 6,565 | $70.29 |
| Q4 2024 | +3,475 | Add 52.93% | 10,040 | $65.73 |
| Q1 2025 | -1,750 | Reduce 17.43% | 8,290 | $70.69 |
| Q2 2025 | -290 | Reduce 3.50% | 8,000 | $54.97 |
| Q3 2025 | +5,150 | Add 64.38% | 13,150 | $54.16 |
Mario Gabelli's BioMarin Pharmaceutical Investment FAQs
Mario Gabelli first purchased BioMarin Pharmaceutical Inc. (BMRN) in Q4 2017, acquiring 2,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held BioMarin Pharmaceutical Inc. (BMRN) for 32 quarters since Q4 2017. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli's largest addition to BioMarin Pharmaceutical Inc. (BMRN) was in Q1 2021, adding 10,774 shares worth $814,000. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 13,150 shares of BioMarin Pharmaceutical Inc. (BMRN), valued at approximately $712,204. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, BioMarin Pharmaceutical Inc. (BMRN) represents approximately 0.01% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli's peak holding in BioMarin Pharmaceutical Inc. (BMRN) was 13,150 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.